HUCBC Treatment Improves Cognitive Outcome in Rats With Vascular Dementia

Background and purpose: Vascular dementia (VaD) is the second common cause of dementia after Alzheimer’s disease in older people. Yet, there are no FDA approved drugs specifically for VaD. In this study, we have investigated the therapeutic effects of human umbilical cord blood cells (HUCBC) treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkat, Poornima, Culmone, Lauren, Chopp, Michael, Landschoot-Ward, Julie, Wang, Fengjie, Zacharek, Alex, Chen, Jieli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461871/
https://www.ncbi.nlm.nih.gov/pubmed/32973489
http://dx.doi.org/10.3389/fnagi.2020.00258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461871/
https://www.ncbi.nlm.nih.gov/pubmed/32973489
http://dx.doi.org/10.3389/fnagi.2020.00258

Ejemplares similares